Viridian Therapeutics, Inc.\DE
Customers
0
None disclosed
Suppliers
1
1 disclosed
Latest period
Sep 30, 2026
10-Q filed 2026-11-04
How this is estimated
Dollars are the disclosed share × the discloser's revenue for that period, using the latest full year where available, or federal dollars obligated. Each side has its own scale.Suppliers 1
Companies that sell to VRDN, as either company disclosed it. Percentages are a share of the supplier's revenue. 1 active, 0 lapsed.
| Company | % of supplier's revenue | Est. $ from VRDN | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| WuXi Non-SEC WuXi |
Named | — | 3M 2026-09-30 | — | Active | 10-Q 2026-11-04 |
We currently rely on outside vendors, including WuXi, to manufacture our commercial supplies of veligrotug and our clinical supplies of our product candidates, and we plan to continue relying on third parties to manufacture veligrotug and our product candidates, devices, or device components, if approved, on a commercial scale. | ||||||
Alerts are coming
Get an email when VRDN's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.